Fundz

Altesa Bio Sciences reported raising $35 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEJan 05, 2023

Amount Raised

$35 Million

$35 Million sold, per SEC Form D (first sale Dec 22, 2022)

Round Type

Venture

College ParkHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Altesa BioSciences that raised within 45 days of this round, from Fundz verified event records.

  • INVO Fertility, Inc. raised $300K (Seed) on February 3, 2023.
  • Kiora Pharmaceuticals raised $200K (Seed) on February 3, 2023.
  • Spine BioPharma raised $13M on February 3, 2023.
  • Koios Medical raised $8M on February 3, 2023.
  • Streamex Corp. raised $2M (Seed) on February 3, 2023.
  • Perspective Therapeutics raised $55M on February 3, 2023.

Who to call at Altesa BioSciences, and when

A new round usually means Altesa BioSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Altesa BioSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Altesa BioSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Altesa BioSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Altesa BioSciences

Location

1930 Harvard Avenue

College Park, Georgia, United States

About

Altesa BioSciences is a clinical-stage pharmaceutical company dedicated to developing new treatments for age-old threats to human health: high-consequence viral infections. These infections are particularly severe in vulnerable people, including those with chronic health conditions, like lung diseases, as well as the elderly and many people in underserved communities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Altesa BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBrett G., Executive Officer, Director, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Altesa BioSciences's next move

See what Strategic adds

Altesa BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.